For the Quarter Ending September 2025
North America
• In USA, the Metoprolol Succinate Price Index rose by 2.63% quarter-over-quarter, driven by modest supply tightening.
• The average Metoprolol Succinate price for the quarter was approximately USD 54790.00/MT, based on settlements.
• Metoprolol Succinate Spot Price remained stable as contract rollovers supported the Price Index and margins.
• Metoprolol Succinate Price Forecast indicates limited upside near term given balanced inventories and steady demand.
• Rising feedstock costs modestly affected the Metoprolol Succinate Production Cost Trend, pressuring some contract renewal levels.
• Metoprolol Succinate Demand Outlook is steady from generics and buying, cushioning against Price Index declines.
• Inventory drawdowns improved export availability, supporting the Metoprolol Succinate Price Index despite soft spot activity.
• Several manufacturers operated normally with limited outages, sustaining supply, stabilizing the Metoprolol Succinate Price Index.
Why did the price of Metoprolol Succinate change in September 2025 in North America?
• Tighter contract allocations reduced available spot volumes, tightening supply versus steady demand and supporting prices.
• Higher active pharmaceutical ingredient feedstock costs and increased freight rates elevated production costs and pressured margins.
• Stable procurement by generic manufacturers and limited factory outages maintained demand certainty, constraining downward Price Index movement.
APAC
• In China, the Metoprolol Succinate Price Index rose by 2.6% quarter-over-quarter in Q3 2025, reflecting modest demand recovery.
• The average Metoprolol Succinate price for the quarter was approximately USD 54650.00/MT, reflecting contract settlements.
• Metoprolol Succinate Spot Price displayed limited volatility as buyers awaited contract conclusions and inventory adjustments.
• Metoprolol Succinate Price Forecast remains cautiously positive due to steady offtake and constrained supply availability.
• Metoprolol Succinate Production Cost Trend indicated pressure from raw material import costs and energy tariffs.
• Metoprolol Succinate Demand Outlook strengthened for generics manufacturing and hospital restocking, supporting tighter market balances.
• Metoprolol Succinate Price Index movements correlated with export nominations and inventory draws at coastal terminals.
• Operational disruptions at select Metoprolol Succinate producers tightened availability, influencing buying and contract renewal behaviors.
Why did the price of Metoprolol Succinate change in September 2025 in APAC?
• Stronger institutional purchases reduced readily available inventories, tightening supply and supporting marginal price increases domestically.
• Higher material import costs and energy tariffs increased production cost pressure, constraining margins for manufacturers.
• Logistics congestion and phased export nominations delayed shipments, amplifying tightness and accelerating contract negotiations activity.
Europe
• In Germany, the Metoprolol Succinate Price Index rose by 2.595% quarter-over-quarter, driven by limited supply.
• The average Metoprolol Succinate price for the quarter was approximately USD 54730/MT, reported by sources.
• Metoprolol Succinate Spot Price gains reflected constrained European synthesis capacity while Price Index signaled tightening.
• Rising raw material and energy costs pushed the Metoprolol Succinate Production Cost Trend, pressuring margins.
• The Metoprolol Succinate Demand Outlook improved due to stable generic uptake and hospital procurement cycles.
• Near-term Metoprolol Succinate Price Forecast suggests upward bias amid steady export demand and low inventories.
• Operational disruptions at key German producers tightened availability, reflecting in the Metoprolol Succinate Price Index.
• Inventory drawdowns and recent tender awards supported Metoprolol Succinate price resilience despite competitive import offers.
Why did the price of Metoprolol Succinate change in September 2025 in Europe?
• Supply tightness from maintenance and regulatory lead times reduced available volumes, lifting market prices short-term.
• Higher feedstock and energy costs increased production expenses, translating into upward pressure on supplier pricing.
• Improved procurement activity and export demand combined with logistic constraints to tighten availability regionally notably.
For the Quarter Ending March 2025
North America
The U.S. Metoprolol Succinate market experienced a gradual yet consistent price increase across Q1 2025, driven by a combination of supply constraints, trade policy shifts, and rising operational costs. January saw a modest price uptick as U.S. importers front-loaded shipments to avoid the impending 10% tariff on Chinese goods set for February 1. This pre-tariff inventory build-up, combined with Chinese Lunar New Year-related demand and higher energy costs, created short-term supply pressure and minor price escalation. Additional strain emerged from port congestion in California, triggered by wildfire-related labor shortages and adverse weather, marginally increasing dwell times and shipping costs.
In February, prices rose more sharply as the 10% tariff took effect, raising landed costs and intensifying procurement challenges. Export prices from China surged amid strong international demand and manufacturing cost inflation, further driving price gains. Slower deliveries and falling inventories amplified the strain, while a revival in industrial output and consumer sentiment fueled demand growth.
March continued the upward trend, with added complexity from China’s retaliatory tariff hike to 125%, escalating sourcing costs. Despite easing logistics charges, elevated raw material prices and steady pharmaceutical demand maintained a tight supply landscape. Proactive inventory strategies prevailed as buyers navigated persistent supply-side inflation and geopolitical uncertainty.
Asia Pacific
Throughout Q1 2025, Metoprolol Succinate prices in China trended upward, supported by firm pharmaceutical demand, seasonal supply disruptions, and intensified global trade activity. In January, prices recorded a modest increase, driven by steady offtake from healthcare sectors and reduced production activity ahead of the Lunar New Year. As manufacturers scaled back operations during the holiday period, inventory replenishment efforts by pharmaceutical buyers created mild supply tightness. Exporters also expedited shipments in anticipation of the impending U.S. tariff hike, marginally impacting domestic availability and supporting slight price gains.
February witnessed a more pronounced price increase amid tightening inventories and sustained downstream demand. Rising raw material costs and trade-related uncertainty, especially following the U.S. implementation of a 10% import tariff, led to heightened volatility. The resulting wave of bulk purchases by international buyers contributed to supply constraints. A rebound in China’s PMI, reflecting renewed industrial activity, further reinforced pharmaceutical demand and pricing momentum.
In March, export prices surged significantly as inventories declined and overseas procurement accelerated due to escalating U.S.–China trade tensions. With the PMI reaching a year-high of 50.5, domestic industrial output surged, pushing up raw material costs. Strong international interest, supported by lower freight rates, sustained the bullish pricing trajectory through quarter-end.
Europe
During Q1 2025, Metoprolol Succinate prices in Germany followed a gradually upward trajectory, supported by stable downstream demand and mounting cost pressures from origin markets. In January, prices saw a minor increase as sentiment in the German economy improved, encouraging moderate growth in new orders from the pharmaceutical sector. While early Lunar New Year demand from Asia and Red Sea logistics disruptions led to extended lead times, efficient supply chain management and adequate inventories ensured market stability, contributing only modestly to price movement.
February marked a continuation of this upward trend, driven by low domestic inventories and strengthening demand. The depreciation of the euro against the U.S. dollar elevated procurement costs, while firm pricing in China—Germany’s key supplier—added upward pressure. Although freight rates declined, offering marginal cost relief, they were insufficient to fully counteract the impact of rising input costs and steady consumption by pharmaceutical and healthcare industries.
By March, pricing momentum accelerated as Chinese export prices climbed further due to higher production costs, directly influencing import values. Germany’s improving Manufacturing PMI and declining inflation signaled stronger economic fundamentals, which supported firm demand. Despite ongoing currency volatility, the consistent offtake from pharmaceutical manufacturers and solid international sourcing costs sustained the bullish trend across the German Metoprolol Succinate market.
For the Quarter Ending December 2024
North America
In Q4 2024, Metoprolol Succinate prices in the USA experienced notable fluctuations, influenced by changing market dynamics. October saw a sharp price increase driven by rising demand, bolstered by Federal Reserve rate cuts that boosted consumer confidence. However, ongoing port congestion, labor strikes, and concerns over potential tariff hikes under President-elect Donald Trump disrupted supply chains, worsening the supply-demand imbalance and pushing prices higher.
By November, the market shifted as demand weakened under the pressure of inflation and high interest rates. The stronger U.S. dollar reduced import costs, and the resolution of the ILA strike helped ease logistical challenges. These factors, along with strong inventory levels, enabled suppliers to reduce prices, passing on savings to consumers.
In December, Metoprolol Succinate prices continued to decline, driven by lower consumer confidence, slower seasonal demand, and proactive inventory buildup in anticipation of January strikes and the Chinese Lunar New Year. Inflation concerns and tariff uncertainties led to more cautious purchasing, while ample supply and competitive pricing strategies exerted downward pressure. By the end of Q4, Metoprolol Succinate was priced at USD 50,250 per metric ton (USP, FDA) CFR Los Angeles, marking a decline from earlier in the quarter. Overall, Q4 was characterized by volatility, with the market ultimately trending downward.
Asia Pacific
In Q4 2024, the Metoprolol Succinate market in China experienced a dynamic pricing trend, shaped by a range of economic and market forces. In October, prices saw a notable increase, driven by the rebound of China's manufacturing sector, supported by government stimulus measures. Rising domestic and export demand, alongside monetary easing and a weaker yuan, boosted consumer confidence and external orders, allowing suppliers to raise prices.
However, by November, the upward trend reversed. High inventory levels, sluggish domestic demand, and weaker international orders—especially from the USA and Europe—resulted in an oversupply. The decline in crude oil prices further lowered operational costs, prompting manufacturers to reduce prices to stay competitive in a softer market.
In December, prices continued to decline due to weakened consumer demand amidst ongoing disinflation in China. Adjustments in procurement strategies by pharmaceutical companies and international buyers further contributed to the slowdown in demand. Reduced foreign orders during the holiday season led to excess inventory, pushing suppliers to cut prices in an effort to clear stock before year-end. Overall, Q4 saw a shift from October’s price increases to a downward trend in the following months, driven by fluctuating demand and evolving market conditions. By the end of Q4, Metoprolol Succinate was priced at USD 50,000 per metric ton FOB Shanghai in China.
Europe
In Q4 2024, Metoprolol Succinate prices in Germany exhibited fluctuating trends throughout the quarter. October saw a notable price increase, driven by improved business sentiment fueled by optimism about economic recovery and the European Central Bank’s third interest rate cut to 3.25%. This monetary easing encouraged spending and investment, while preemptive inventory buildup and ongoing supply chain challenges, such as delays at Hamburg’s ports, contributed to upward price pressure.
However, by November, the trend shifted. Weak demand from end-sectors and fading inflationary concerns led to a reduction in price pressures. A sharp decline in consumer spending and retail activity in Germany, coupled with a 1.9% drop in energy prices, lowered operational costs, enabling suppliers to offer more competitive prices.
The downward movement continued into December, driven by subdued demand from key sectors, cautious purchasing behavior amid lingering inflation concerns, and higher import costs due to the euro’s depreciation. Additionally, high inventories and year-end stock clearance efforts further pushed prices down, while harsh winter conditions disrupted consumer activity and logistics, exacerbating the decline. Overall, Q4 marked a shift from initial optimism to growing economic caution, which significantly impacted pricing. By the end of Q4, Metoprolol Succinate was priced at USD 50,150 per metric ton CFR Hamburg.
For the Quarter Ending September 2024
North America
In Q3 2024, the North American market for Metoprolol Succinate saw a notable increase in prices, driven by several key factors. A primary catalyst for this rise was the surge in demand for the medication, which was bolstered by an improved economic outlook and heightened consumer confidence. As consumers gained greater financial security, their willingness to purchase pharmaceuticals like Metoprolol Succinate increased, exerting upward pressure on prices.
However, this favorable demand was countered by supply chain challenges that limited product availability. Factors such as port congestion and adverse weather conditions disrupted the movement of goods, leading to supply constraints that further propelled price increases. Additionally, uncertainties related to the ongoing Red Sea crisis exacerbated shipping costs, prompting businesses to adopt more cautious procurement strategies. These external pressures compounded the already difficult supply environment.
By the conclusion of Q3 2024, the price of Metoprolol Succinate reached USD 58,800 per metric ton (USP, FDA) CFR Los Angeles. This price not only underscored a continued upward trend but also mirrored the prevailing positive sentiment in the market, shaped by the complex interaction between demand dynamics and supply-side constraints.
Asia Pacific
In the third quarter of 2024, Metoprolol Succinate prices in the APAC region exhibited a notable upward trajectory, influenced by several critical factors. A major driver of this price increase was strong global demand, especially from key markets, where foreign importers proactively secured sufficient supplies to guard against potential shortages. This heightened demand was further exacerbated by logistical challenges, such as disruptions in global shipping routes and escalating freight costs, which contributed to the overall price escalation. China became the epicenter of these developments, experiencing the most significant price fluctuations in the region. The country saw a notable rise in overseas demand coupled with a tightening supply scenario, leading to substantial price volatility. Overall, the quarter showcased a positive pricing landscape, marked by steady increases in prices throughout the period. By the conclusion of Q3 2024, Metoprolol Succinate was priced at USD 56,200 per metric ton (USP, FDA) FOB Shanghai. This final price reflects a robust and optimistic pricing sentiment over the quarter, emphasizing the persistent demand and supply pressures that have been shaping the market dynamics.
Europe
In Q3 2024, the European market for Metoprolol Succinate experienced a significant upward trend in pricing, influenced by several key factors. Strong demand from stable end-user needs provided a solid foundation for price increases. Simultaneously, a decrease in inflationary pressures across the region enhanced consumer purchasing power, further driving Metoprolol Succinate prices upward. The ongoing Red Sea crisis also played a crucial role, prompting retailers to proactively replenish their inventories in anticipation of potential disruptions during the critical Christmas trading season. This urgency, combined with disruptions in shipping lanes, sustained elevated demand and contributed to the overall price surge. Germany stood out as the region experiencing the most pronounced price fluctuations, mirroring the broader trends observed across Europe. Throughout the quarter, prices consistently trended upwards, with a 1% increase compared to the previous quarter. Seasonal patterns and correlations in price movements were evident, indicating synchronized growth in the market. Despite challenges such as fluctuating freight rates and logistical issues, the pricing environment remained predominantly favorable. By the end of the quarter, Metoprolol Succinate was priced at USD 57,950 per metric ton CFR Hamburg, underscoring the prevailing positive sentiment within the market.
